Tao Yu

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Johns Hopkins University, Kala Pharmaceuticals, Inc.. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Yu. Retrieved from https://idiyas.com/inventor/tao-yu-9wwlolmj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 60(Granted Patents)

Company Filing History:

11 out of 3,806

Johns Hopkins University

patents

4 out of 53

Kala Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12178920 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2024-12-31),

2. 11872318 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2024-01-16),

3. 11642317 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2023-05-09),

4. 10736854 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2020-08-11),

5. 10568975 - Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof (2020-02-25),

6. 10556017 - Lipid-based drug carriers for rapid penetration through mucus linings (2020-02-11),

7. 10058511 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2018-08-28),

8. 9889208 - Lipid-based drug carriers for rapid penetration through mucus linings (2018-02-13),

9. 9737491 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2017-08-22),

10. 9532955 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2017-01-03),

11. 9393213 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2016-07-19),

12. 9393212 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2016-07-19),

13. 9056057 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2015-06-16),

Title: The Innovative Contributions of Inventor Tao Yu

Introduction

Tao Yu, an accomplished inventor based in Baltimore, MD, has made significant strides in the field of pharmaceutical technologies. With a portfolio of 13 patents, he has contributed valuable innovations that enhance the efficacy of drug delivery systems.

Latest Patents

Among his latest inventions are nanocrystals, compositions, and methods aimed at improving particle transport in mucus. These innovations focus on creating mucus-penetrating particles (MPP) with little to no use of polymeric carriers. By modifying surface coatings of low water-solubility pharmaceutical agents, his methods facilitate efficient transport through mucus barriers in the body. This technology is poised to support various applications, including drug delivery, imaging, and diagnostics, particularly when particles must traverse mucosal barriers.

Career Highlights

Tao Yu's career includes pivotal roles at prominent organizations such as The Johns Hopkins University and Kala Pharmaceuticals, Inc. His tenure at these institutions highlights his commitment to advancing research and development in the pharmaceutical arena.

Collaborations

Throughout his career, Tao has collaborated with esteemed professionals in the field, including Justin Scot Hanes and Ming Yang. These partnerships have contributed to his innovative research and the successful development of his patented technologies.

Conclusion

In conclusion, Tao Yu stands out as a prominent inventor whose work is shaping the future of drug delivery systems. His innovative approaches to overcoming mucus barriers have the potential to revolutionize how pharmaceuticals are administered, ensuring better outcomes for patients across a wide variety of applications.

Profile summary based on public USPTO records.